NO20014033D0 - Overflate modifikasjon av lamellerte partikler - Google Patents

Overflate modifikasjon av lamellerte partikler

Info

Publication number
NO20014033D0
NO20014033D0 NO20014033A NO20014033A NO20014033D0 NO 20014033 D0 NO20014033 D0 NO 20014033D0 NO 20014033 A NO20014033 A NO 20014033A NO 20014033 A NO20014033 A NO 20014033A NO 20014033 D0 NO20014033 D0 NO 20014033D0
Authority
NO
Norway
Prior art keywords
surface modification
laminated particles
laminated
particles
modification
Prior art date
Application number
NO20014033A
Other languages
English (en)
Other versions
NO20014033L (no
Inventor
Stanley Steward Davis
Andrew Wells
Original Assignee
West Pharm Serv Drug Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by West Pharm Serv Drug Res Ltd filed Critical West Pharm Serv Drug Res Ltd
Publication of NO20014033D0 publication Critical patent/NO20014033D0/no
Publication of NO20014033L publication Critical patent/NO20014033L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y10S977/775—Nanosized powder or flake, e.g. nanosized catalyst
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
NO20014033A 1999-03-06 2001-08-20 Overflate modifikasjon av lamellerte partikler NO20014033L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9905136.9A GB9905136D0 (en) 1999-03-06 1999-03-06 Surface modification of lamellar particles
PCT/GB2000/000755 WO2000053230A2 (en) 1999-03-06 2000-03-03 Surface modification of lamellar particles

Publications (2)

Publication Number Publication Date
NO20014033D0 true NO20014033D0 (no) 2001-08-20
NO20014033L NO20014033L (no) 2001-10-10

Family

ID=10849075

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014033A NO20014033L (no) 1999-03-06 2001-08-20 Overflate modifikasjon av lamellerte partikler

Country Status (10)

Country Link
US (1) US6635254B2 (no)
EP (1) EP1159011A2 (no)
JP (1) JP2002538223A (no)
AU (1) AU2925100A (no)
CA (1) CA2364444A1 (no)
GB (1) GB9905136D0 (no)
NO (1) NO20014033L (no)
NZ (1) NZ513696A (no)
WO (1) WO2000053230A2 (no)
ZA (1) ZA200106902B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US20040248804A1 (en) * 2003-05-01 2004-12-09 Khurshid Iqbal Nasal administration of the LH-RH analog Leuprolide
US20060263350A1 (en) * 2003-09-26 2006-11-23 Fairfield Clinical Trials Llc Combination antihistamine medication
FR2870741B1 (fr) 2004-05-25 2008-03-14 Coletica Sa Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant.
US9492400B2 (en) 2004-11-04 2016-11-15 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
WO2007070682A2 (en) 2005-12-15 2007-06-21 Massachusetts Institute Of Technology System for screening particles
JP2009534309A (ja) 2006-03-31 2009-09-24 マサチューセッツ インスティテュート オブ テクノロジー 治療剤の標的化送達のためのシステム
WO2007133807A2 (en) * 2006-05-15 2007-11-22 Massachusetts Institute Of Technology Polymers for functional particles
WO2007150030A2 (en) * 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
WO2008019142A2 (en) * 2006-08-04 2008-02-14 Massachusetts Institute Of Technology Oligonucleotide systems for targeted intracellular delivery
WO2008098165A2 (en) 2007-02-09 2008-08-14 Massachusetts Institute Of Technology Oscillating cell culture bioreactor
WO2008124639A2 (en) * 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Poly (amino acid) targeting moieties
WO2008124634A1 (en) * 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Polymer-encapsulated reverse micelles
MX2010003642A (es) 2007-10-12 2010-08-09 Massachusetts Inst Technology Nanotecnologia de vacuna.
US8343497B2 (en) 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8277812B2 (en) 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412273D0 (en) * 1994-06-18 1994-08-10 Univ Nottingham Administration means
US5431620A (en) 1994-07-07 1995-07-11 Beckman Instruments, Inc. Method and system for adjusting centrifuge operation parameters based upon windage
GB9416884D0 (en) 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
KR960016882A (ko) * 1994-11-01 1996-06-17 강재헌 치주염치료를 위한 서방출형 생분해성 제제
GB9514285D0 (en) * 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery
US5665428A (en) * 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
FR2766706B1 (fr) * 1997-07-30 2001-05-25 Biovector Therapeutics Sa Complexes particulaires stables de charge globale neutre ou negative de structure multilamellaire composes par au moins une substance biologiquement active globalement anionique et un constituant cationique, leur preparation et utilisation

Also Published As

Publication number Publication date
ZA200106902B (en) 2003-11-21
WO2000053230A3 (en) 2001-08-02
WO2000053230A2 (en) 2000-09-14
CA2364444A1 (en) 2000-09-14
AU2925100A (en) 2000-09-28
US6635254B2 (en) 2003-10-21
NO20014033L (no) 2001-10-10
GB9905136D0 (en) 1999-04-28
NZ513696A (en) 2003-03-28
US20020068091A1 (en) 2002-06-06
EP1159011A2 (en) 2001-12-05
JP2002538223A (ja) 2002-11-12

Similar Documents

Publication Publication Date Title
NO20014033L (no) Overflate modifikasjon av lamellerte partikler
GB2379271B (en) True relative amplitude migration
DK0954410T3 (da) Fremstilling afämànstrede slibeoverflader
SE9701691D0 (sv) Förfarande för framställning av dekorativt laminat och användning därav
FI980640A0 (fi) Ytbelagd traebaserad skiva och foerfarande foer ytbelaeggning av en traebaserad skiva
DK1034217T3 (da) Phosphonatosiloxanbehandlede uorganiske partikler
DE69912161D1 (de) Uv-absorbierende partikel
DK1181018T3 (da) Ziprasidonsuspension
GB0016864D0 (en) Bonding of rubber particles
DE60035330D1 (de) Oberflächenwellenfilter
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
DE69900514D1 (de) Herstellung von Polyalkylsilsesquioxan-Partikeln
GB9929521D0 (en) Bonded products and methods of fabrication therefor
DE60036504D1 (de) Feine Kaliumtitanat-Teilchen
AU2001272328A1 (en) Surface for the immobilisation of ligands
TW471684U (en) Write-once compact disk structure of surface plasma ultra-resolution inorganic material type
DE60036041D1 (de) Kantenreflexions-Oberflächenwellenfilter
DE69937225D1 (de) Enzympartikel
DE29811080U1 (de) Dekoratives Firstenddeckel-Paar
DE50014851D1 (de) Feste partikel
NO20022446D0 (no) Etere av O-desmetyl-venlafaxine
KR970063582U (ko) 안경다리의 움직이는 장식구조
DE50007219D1 (de) Akustisches oberflächenwellenfilter
GB9904203D0 (en) Sound proof ceramic adhesive
DE29901353U1 (de) Dekoratives Flächenelement

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application